316 related articles for article (PubMed ID: 7034932)
1. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
Klastersky J; Sculier JP; Nicaise C; Weerts D; Mairesse M; Libert P; Rocmans P; Michel J; Ferremans W
Cancer Treat Rep; 1983; 67(7-8):727-30. PubMed ID: 6347374
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
Hainsworth JD; Porter LL; Johnson DH; Hande KR; Wolff SN; Birch R; Enas G; Greco FA
Cancer Treat Rep; 1986 Mar; 70(3):339-41. PubMed ID: 3955545
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
[TBL] [Abstract][Full Text] [Related]
7. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
König HJ; Arnold E; Walter M; Sander U
Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
[TBL] [Abstract][Full Text] [Related]
9. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
Wander HE; Nagel GA
Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
Kelsen DP; Bains M; Chapman R; Golbey R
Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung.
Fraile RJ; Samson MK; Baker LH; Talley RW
Cancer Treat Rep; 1979; 63(11-12):1983-7. PubMed ID: 230896
[TBL] [Abstract][Full Text] [Related]
12. [Antineoplastic chemotherapy for bronchial carcinoma].
Tanneberger S
Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
[TBL] [Abstract][Full Text] [Related]
13. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
Niederle N; Schütte J; Schmidt CG; Seeber S
Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy of primary adenocarcinoma of the lung using adriamycin, ACNU, and vindesine].
Yoneda S; Min KY; Honma T; Yoshida S; Nakagawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):961-6. PubMed ID: 6575723
[TBL] [Abstract][Full Text] [Related]
16. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
17. cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.
Gralla RJ; Cvitkovic E; Golbey RB
Cancer Treat Rep; 1979; 63(9-10):1585-8. PubMed ID: 498158
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
Daugaard G; Hansen HH; Rørth M
Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.
Knost JA; Greco FA; Hande KR; Richardson RL; Fer MF; Oldham RK
Cancer Treat Rep; 1981; 65(11-12):941-5. PubMed ID: 7028255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]